|
 |
European Biopharmaceutical Review
|
| Establishing an effective biomedical tissue management system is an integral part of moves to standardise and harmonise biobanking practices, explains Dr Achim Quandt of QIAGEN GmbH
In cancer research, as with other areas of biomedical research, a major issue facing researchers is the great variation in the methods employed by different labs for collecting, storing and analysing biological samples. This affects the quality and comparability of research data, and can only be resolved by the widespread adoption of standardised and quality-controlled protocols. Such protocols in case-control, cohort and other epidemiological studies are required to facilitate the discovery and validation of relevant disease biomarkers and, ultimately, the development of diagnostics and therapeutics.
Initiatives at the national and international level to standardise and harmonise biobanking practices have already begun. In Europe, the European Commission and the Wellcome Trust organised a conference in 2005 to discuss the current state of biobanks in Europe and to propose future strategies, including greater harmonisation of programmes and standards and greater standardisation of protocols. Proposals will be submitted to the 7th Framework Programme for Research and Technological Development (FP7), an EU programme with a budget of over ˆ50 billion to fund trans-European research. |
Read full article >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
 |

 |
Industry Events |
 |
BioPharma India Convention 2010
6-8 December 2010, Mumbai, India
BioPharma India Convention 2010 is where global and Indian pharmaceutical companies, biotechs, CMOs, CROs, academic institutions and many others come together to assess the latest trends, partnerships and solutions. Held concurrently are the World Pharma Trials India 2010, Biologic Manufacturing World India 2010 and R&D Partnering World India 2010.
More info >> |
|
 |
News and Press Releases |
 |
The highest performance in its class
Shimadzu, one of the worldwide leading manufacturers in analytical instrumentation, has launched a new GCMS-QP2010 Ultra gas chromatograph mass spectrometer (GC/MS) offering the highest performance in its class. It provides fast data measurement speed with five times higher sensitivity than previous models. In addition to improving laboratory productivity for high-speed analysis, it also offers improved applicability for comprehensive two-dimensional gas chromatography (GCxGC), which can achieve ultra high separation. It is also the first GC/MS system to have environmentally friendly features for saving power consumption and carrier gas.
More info >> |
|
 |